Research Calls I
-
Upgrades:
- Alkami Technology (ALKT) upgraded to Overweight from Equal-Weight at Stephens; tgt $40
- CareTrust REIT (CTRE) upgraded to Buy from Hold at Deutsche Bank; tgt $31
- CervoMed (CRVO) upgraded to Buy from Neutral at Chardan Capital Markets; tgt $14
- Houlihan Lokey (HLI) upgraded to Overweight from Underweight at Morgan Stanley; tgt lowered to $190
- Intel (INTC) upgraded to Neutral from Underperform at BofA Securities; tgt raised to $25
- Invitation Homes (INVH) upgraded to Outperform from Neutral at Mizuho; tgt raised to $36
- IREN Limited (IREN) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $12
-
Downgrades:
- American Eagle (AEO) downgraded to Underweight from Equal Weight at Barclays; tgt lowered to $10
- Arvinas (ARVN) downgraded to Neutral from Buy at Goldman; tgt lowered to $15
- Cipher Mining (CIFR) downgraded to Neutral from Overweight at JP Morgan
- Federal Realty (FRT) downgraded to Hold from Buy at Truist; tgt lowered to $105
-
Others:
- 89bio (ETNB) initiated with a Buy at Citigroup; tgt $25
- Alkermes Plc (ALKS) initiated with a Sector Perform at RBC Capital Mkts; tgt $40
- Apogee Therapeutics (APGE) initiated with a Buy at Citigroup; tgt $95
- ArcBest (ARCB) initiated with a Buy at Truist; tgt $93
- BioNTech (BNTX) initiated with a Buy at Citigroup; tgt $145
- CF Industries (CF) initiated with a Neutral at Goldman; tgt $86
- C.H. Robinson (CHRW) initiated with a Buy at Truist; tgt $115
- Corteva (CTVA) initiated with a Buy at Goldman; tgt $71
- Cybin (CYBN) initiated with a Buy at Guggenheim; tgt $35
- Exact Sciences (EXAS) initiated with a Sector Perform at RBC Capital Mkts; tgt $52
- Expeditors Intl (EXPD) initiated with a Hold at Truist; tgt $110
- FedEx (FDX) initiated with a Buy at Truist; tgt $305
- FMC Corp (FMC) initiated with a Buy at Goldman; tgt $51
- GH Research PLC (GHRS) initiated with a Buy at Guggenheim; tgt $32
- GXO Logistics (GXO) initiated with a Hold at Truist; tgt $40
- J.B. Hunt Transport (JBHT) initiated with a Hold at Truist; tgt $165
- Kiniksa Pharmaceuticals (KNSA) initiated with a Buy at Citigroup; tgt $40
- Perspective Therapeutics (CATX) initiated with a Buy at H.C. Wainwright; tgt $10